Tempest Therapeutics, Inc. Common Stock (TPST) is a publicly traded Healthcare sector company. As of September 8, 2026, TPST trades at $1.00 with a market cap of $17.04M and a P/E ratio of -0.16. TPST moved +0.00% today. Year to date, TPST is -28.22%; over the trailing twelve months it is -81.26%. Its 52-week range spans $0.84 to $6.57. Rallies surfaces TPST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TPST, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $17.04M |
| P/E Ratio | -0.16 |
| EPS | $-6.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.57 |
| 52-Week Low | $0.84 |
| Volume | 66.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.26M |
| Gross Margin | 0.00% |
TPST analyst coverage data. Average price target: $0.00.